Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | CDK1 | P06493 | 1/20 | 0.31 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.31 |
| ▸ | MGMT | P16455 | 1/20 | 0.31 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.31 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18194708 | 0.95 | MAPT (0.47) | MAPK1MAPTCDK1CCNB1MGMT | |
| SCHEMBL23181 | 0.88 | MAPK1 (0.55) | MAPK1MAPTCDK1CCNB1MGMT | |
| Hydrogen Sulfide SCHEMBL20395887 | 0.85 | MAPK1 (0.53) | MAPK1MAPTCDK1CCNB1MGMT | |
| SCHEMBL16222144 | 0.83 | MAPT (0.44) | MAPK1MAPT | |
| SCHEMBL10798317 | 0.81 | MAPK1 (0.50) | MAPK1MAPTCDK1CCNB1MGMT | |
| SCHEMBL4115128 | 0.77 | MAPT (0.47) | MAPK1MAPTHSD17B10 | |
| SCHEMBL21875991 | 0.77 | MAPK1 (0.47) | MAPK1MAPTCDK1CCNB1MGMT | |
| SCHEMBL11803039 | 0.77 | MAPK1 (0.47) | MAPK1MAPTPOLB | |
| SCHEMBL4111687 | 0.77 | MAPK1 (0.47) | MAPK1MAPTPOLB | |
| SCHEMBL154305 | 0.77 | MAPT (0.47) | MAPK1MAPTCDK1CCNB1MGMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11713377-B2 | Polyolefin pipe | UPONOR INNOVATION AB (SE) | 2023-08-01 | — | — | US | disclosed |
| US-9963573-B2 | Polyolefin pipe | UPONOR INNOVATION AB (SE) | 2018-05-08 | — | — | US | disclosed |
| US-20180057644-A1 | Polyolefin Pipe | UPONOR INNOVATION AB (SE) | 2018-03-01 | — | — | US | disclosed |
| US-20170114193-A1 | Polyolefin Pipe | UPONOR INNOVATION AB (SE) | 2017-04-27 | — | — | US | disclosed |
| US-20160319162-A1 | THERMALLY RESISTANT ANAEROBICALLY CURABLE COMPOSITIONS | HENKEL AG & CO. KGAA (DE) | 2016-11-03 | — | — | US | disclosed |
| US-20160160085-A1 | BONDING COMPOSITION AND COMPONENT THEREOF, AND METHOD OF USING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2016-06-09 | — | — | US | disclosed |
| US-20160130420-A1 | Polyolefin Pipe | UPONOR INNOVATION AB (SE) | 2016-05-12 | — | — | US | disclosed |
| US-8815988-B2 | Resin compound, resin composition, and resin-molded product | FUJI XEROX CO., LTD. (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8691984-B2 | Method of storing triallyl isocyanurate | NIPPON KASEI CHEMICAL COMPANY LIMITED (JP) | 2014-04-08 | — | — | US | disclosed |
| US-20130158173-A1 | RESIN COMPOUND, RESIN COMPOSITION, AND RESIN-MOLDED PRODUCT | FUJI XEROX CO., LTD. (JP) | 2013-06-20 | — | — | US | disclosed |
| US-8431697-B2 | Triallyl isocyanurate, triallyl cyanurate and process for producing triallyl isocyanurate | NIPPON KASEI CHEMICAL COMPANY LIMITED (JP) | 2013-04-30 | — | — | US | disclosed |
| US-20130029070-A1 | CROSSLINKABLE COMPOSITION, CROSSLINKED PRODUCT AND METHOD FOR PRODUCTION THEREOF, MULTILAYERED STRUCTURE, CROSSLINKING AGENT, AND COMPOUND AND METHOD FOR PRODUCTION THEREOF | KURARAY CO., LTD. (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20120095225-A1 | METHOD OF STORING TRIALLYL ISOCYANURATE | NIPPON KASEI CHEMICAL COMPANY LIMITED (JP) | 2012-04-19 | — | — | US | disclosed |
| US-20120095223-A1 | TRIALLYL ISOCYANURATE, TRIALLYL CYANURATE AND PROCESS FOR PRODUCING TRIALLYL ISOCYANURATE | NIPPON CHEMICAL COMPANY LIMITED (JP) | 2012-04-19 | — | — | US | disclosed |
| US-20110255156-A1 | MONOMERS AND POLYMERS FOR OPTICAL ELEMENTS | OPHTHONIX, INC. (US) | 2011-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130029070-A1 | CROSSLINKABLE COMPOSITION, CROSSLINKED PRODUCT AND METHOD FOR PRODUCTION THEREOF, MULTILAYERED STRUCTURE, CROSSLINKING AGENT, AND COMPOUND AND METHOD FOR PRODUCTION THEREOF | F2, C9, FGB | MAPK1 4165/4885MAPT 1510/4885CDK1 392/4885 |
| US-20120095225-A1 | METHOD OF STORING TRIALLYL ISOCYANURATE | TIMCC, TST, TMT1A | MAPK1 2473/4885MAPT 1336/4885CDK1 484/4885 |
| US-20120095223-A1 | TRIALLYL ISOCYANURATE, TRIALLYL CYANURATE AND PROCESS FOR PRODUCING TRIALLYL ISOCYANURATE | CA9, CROCC, CA2 | MAPK1 2768/4885MAPT 3564/4885CDK1 1156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.